Browse All

Current Filters

CLEAR FILTER x

TITLE

Efficacy of Symbravo® (MoSEIC(TM) meloxicam and rizatriptan) by Baseline Migraine-associated Disability: Post-hoc Analysis of the INTERCEPT Trial 

Eptinezumab Treatment was Associated with Longer Interictal Periods and Larger Improvements in Quality of Life Than Placebo in Participants with Migraine for Whom 2-4 Prior Preventive Treatments had Failed: A Post Hoc Analysis of the DELIVER Trial